The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients
This guideline is for the use of variable rate intravenous insulin infusion (VRIII) in adult inpatients with medical conditions and diabetes/hyperglycaemia, who require intravenous administration of insulin to keep their blood glucose within the recommended target range during an acute illness or a period of starvation.
This document, produced by the Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP), is designed to guide non-specialist teams in the appropriate and safe use of VRIII.
JBDS-IP is supported by Diabetes UK, the Association of British Clinical Diabetologists (ABCD) and the Diabetes Inpatient Specialist Nurse UK Group. The aim of JBDS-IP is to improve inpatient diabetes care throughout the UK. This is mainly through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.